Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 4 Interventional

Counterpulsation Reduces Infarct Size Pre-PCI for AMI

ClinicalTrials.gov ID: NCT00833612

Public ClinicalTrials.gov record NCT00833612. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 10:05 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-center, Randomized, Controlled Study of Mechanical Left Ventricular Unloading With Counterpulsation to Reduce Infarct Size Pre-PCI for Acute Myocardial Infarction - CRISP AMI

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

Subjects with anterior acute STEMI who receive an IABC before primary PCI will have decreased MI size.

Study identification

NCT ID
NCT00833612
Recruitment status
Completed
Study type
Interventional
Phase
Phase 4
Lead sponsor
Datascope Corp.
Industry
Enrollment
339 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years to 90 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Nov 30, 2008
Primary completion
Feb 28, 2011
Completion
Feb 28, 2011
Last update posted
Jun 26, 2011

2008 – 2011

United States locations

U.S. sites
16
U.S. states
12
U.S. cities
14
Facility City State ZIP Site status
University of Alabama at Birmingham Birmingham Alabama 35294
University of Southern California Los Angeles California 90033
Washington Hospital Center Washington D.C. District of Columbia 20010
Cleveland Clinic Florida Weston Florida 33331
Tufts Medical Center Boston Massachusetts 02111
Caritas St. Elizabeth's Medical Center Boston Massachusetts 02135
Essentia Institute of Rural Health (St Mary's) Duluth Minnesota 55805
University of Nebraska Medical Center Omaha Nebraska 68198
University of Medicine and Dentistry of New Jersey Newark New Jersey 07103
Newark Beth Israel Hospital Newark New Jersey 07112
University of Rochester Medical Center-Strong Memorial Hospital Rochester New York 14627
Duke University Medical Center Durham North Carolina 27705
Lancaster General Hospital Lancaster Pennsylvania 17603
Temple University Hospital Philadelphia Pennsylvania 19140
Allegheny General Hospital Pittsburgh Pennsylvania 15212
University of Texas Health Science Center at Houston Houston Texas 77030

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 24 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00833612, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 26, 2011 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00833612 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →